Skip to content
Acute COVID

Acute COVID

Posted on 14th January 202130th July 2021 by acutecovid

Anti-COVID Therapies

Anti-COVID Therapies

COVID Remdesivir (Viral RNA polymerase inhibitor) COVID Tocilizumab (IL-6 inhibitor) COVID Sarilumab (IL-6 inhibitor) Other Monoclonal Antibodies
CategoriesAnti-COVID Therapies

Post navigation

Previous PostPrevious COVID Microbial Therapy Review (24-48 hours)
Next PostNext COVID Remdesivir (Viral RNA polymerase inhibitor)

Recent Posts

  • Other Monoclonal Antibodies
  • COVID Sarilumab (IL-6 inhibitor)
  • Definitions of terminology used
  • Risk of falls/confusion
  • Patient anxiety

Recent Comments

    Archives

    • July 2021
    • May 2021
    • February 2021
    • January 2021

    Categories

    • About this app
    • Advanced COVID Management
    • Anti-COVID Therapies
    • COVID In-Hospital Treatment
    • COVID Medication Admission
    • COVID Non-invasive Ventilation
    • Critical Care Escalation
    • Critical COVID
    • Defining COVID
    • Emergency Department
    • Initiating NIV in COVID
    • Menu
    • Nursing
    • Nursing assessments
    • Pathophysiology of NIV
    • Sepsis
    • Uncategorised
    • Your wellbeing, mental and physical health

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Proudly powered by WordPress